Successful resolution of pneumonia developed in a patient affected by Crohn’s disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor α inhibitors and conventional immunosuppressive drugs | Zendy

Erika Angelucci | Zendy; Monica Cesarini | Zendy; Piero Vernia | Zendy

Open Access

Successful resolution of pneumonia developed in a patient affected by Crohn’s disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor α inhibitors and conventional immunosuppressive drugs

Author(s) -

Erika Angelucci,

Monica Cesarini,

Piero Vernia

Publication year - 2009

Publication title -

rheumatology international

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.806

H-Index - 74

eISSN - 1437-160X

pISSN - 0172-8172

DOI - 10.1007/s00296-009-1012-6

Subject(s) - medicine , infliximab , rheumatoid arthritis , adalimumab , myasthenia gravis , uveitis , concomitant , immunology , rheumatology , crohn's disease , prednisolone , arthritis , inflammatory bowel disease , disease , tumor necrosis factor alpha

Tumour necrosis factor alpha inhibitors, both infliximab and adalimumab, have been approved for the treatment of both rheumatoid arthritis and Crohn's disease. A slight increase in the risk of infections in patients receiving immunosuppressants and/or biological agents has been reported. Here, we present the case of a 68-year-old woman affected by Crohn's disease, myasthenia gravis, recurrent uveitis and rheumatoid arthritis who developed pneumonia during concomitant treatment with biological agents and conventional immunosuppressive drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research